US Patent Issued to DRAGONBOAT BIOPHARMACEUTICAL (SHANGHAI) on March 17 for "Anti-CSF1R molecules and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,309, issued on March 17, was assigned to DRAGONBOAT BIOPHARMACEUTICAL (SHANGHAI) Co. LTD. (Shanghai).

"Anti-CSF1R molecules and use thereof" was invented by Fangyong Du (Suzhou, China), Peter Peizhi Luo (Suzhou, China), Yan Li (Suzhou, China), Guizhong Liu (Suzhou, China), Xiaohong She (Suzhou, China) and Zhengxi Dai (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to antibodies against human CSF-1R, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof."

The patent was filed on Dec. 23, 2020, under Application No. 17/788,106.

*For further information, including ...